GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Makers Laboratories Ltd (BOM:506919) » Definitions » Deferred Policy Acquisition Costs

Makers Laboratories (BOM:506919) Deferred Policy Acquisition Costs


View and export this data going back to 1991. Start your Free Trial

What is Makers Laboratories Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Makers Laboratories (BOM:506919) Business Description

Traded in Other Exchanges
N/A
Address
54-D, Kandivli Industrial Estate, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti cough Range), and Exylin (Amoxycillin range) among others.